A5021693477- Organ Transplantation Techniques and Outcomes
- Renal Transplantation Outcomes and Treatments
- Organ Donation and Transplantation
- Transplantation: Methods and Outcomes
- Liver Disease and Transplantation
- Renal and Vascular Pathologies
- Pneumocystis jirovecii pneumonia detection and treatment
- Neurological Complications and Syndromes
- Hip and Femur Fractures
- Aldose Reductase and Taurine
- Viral-associated cancers and disorders
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Biomedical Ethics and Regulation
- Renal Diseases and Glomerulopathies
- Hepatitis C virus research
- Dialysis and Renal Disease Management
- Cardiac, Anesthesia and Surgical Outcomes
- Atrial Fibrillation Management and Outcomes
- Bone fractures and treatments
- Trauma, Hemostasis, Coagulopathy, Resuscitation
- Multiple Myeloma Research and Treatments
- Potassium and Related Disorders
- Alcohol Consumption and Health Effects
Sağlık Bilimleri Üniversitesi
2024
Freeman Hospital
2001-2005
Newcastle University
2002-2004
Leicester Royal Infirmary
2004
Newcastle upon Tyne Hospital
2004
Kidneys from non-heart-beating donors (NHBDs) have high rates of delayed graft function (DGF). Use calcineurin inhibitors is associated with a reduction in renal blood flow, which may delay recovery ischaemic acute tubular necrosis.To assess whether daclizumab (DZB) could safely replace tacrolimus the immediate postoperative period, patients were randomized to receive DZB induction and daily mycophenolate mofetil steroids (DZB group) or standard tacrolimus-based triple therapy (control...
Introduction:Estimating intensive care admission of orthopedic patients is challenging because patient variance and multiple comorbidities, primarily in geriatrics, not yet standardized for the planned qualified utility hospital services.This study aimed to reveal perioperative risk scores followed postoperatively investigate efficacy these predicting mortality.Methods: Patients transferred from ward unit (ICU) at any time during their postoperative follow-up 2022 2023 were...
P754 Aims: Daclizumab (DZB) is licensed for prolonged administration post solid organ transplantation and has been shown to reduce the rate of acute rejection. Non-heart-beating (NHBD) kidney recipients have high rates delayed graft function (DGF). Post-operatively NHBD with DGF are exposed more procedures, operative complications longer hospital stays than immediate (IF). Calcineurin inhibitors associated a reduction in renal blood flow which may delay recovery from ischaemic tubular...
P163 Aim: This study is designed to evaluate the extent of tissue injury at time reperfusion by biochemical measurements markers. Method: A prospective control live renal transplants using laparoscpic and open donor Nephrectomy were examined. Laparoscopic surgery was carried out in donors with a single left artery (n = 9), right performed munltiple vessels 8). Perioperative parameters an blood samples measured re-vasculirization both type procedures. Biochemical markers included free...